Cancer Research and Treatment

The Korean Cancer Association (대한암학회)
권호 표지
DOI QR코드

DOI QR Code

Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma

  • Choi, Jinhyun (Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Se-Heon (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Koh, Yoon Woo (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Choi, Eun Chang (Department of Otorhinolaryngology, Yonsei University College of Medicine) ;
  • Lee, Chang Geol (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Keum, Ki Chang (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
  • Received : 2016.04.20
  • Accepted : 2016.06.03
  • Published : 2017.01.15
⟨ Previous Next ⟩

Abstract

Purpose The purpose of this study was to evaluate the clinical outcomes of patients treated with radiotherapy (RT) for a carcinoma of the external auditory canal (EAC) and middle ear. Materials and Methods The records of 32 patients who received RT from 1990 to 2013 were reviewed retrospectively. The Pittsburgh classification was used to stage all the cancers (early stage, T1/T2 [n=12]; advanced stage, T3/T4 or N positive [n=20]). Twenty-one patients (65.6%) were treated with postoperative RT and 11 patients (34.4%) were treated with definitive RT. The median radiation doses for postoperative and definitive RT were 60 Gy and 64.8 Gy, respectively. Chemotherapy was administered to seven patients (21.9%). Results The 5-year overall survival and disease-free survival rates for all patients were 57% and 52%, respectively. The disease control rates for the patients with early stage versus advanced stage carcinoma were 55.6% (5/9) and 50% (6/12) in the postoperative RT group and 66.7% (2/3) and 37.5% (3/8) in the definitive RT group, respectively. Overall, 15 cases (14 patients, 46.7%) experienced treatment failure; these failures were classified as local in four cases, regional in one case, and distant in 10 cases. The median follow-up period after RT was 51 months (range, 7 to 286 months). Conclusion Patients with early stage carcinoma achieved better outcomes when definitive RT was used. Advanced stage carcinoma patients experienced better outcomes with postoperative RT. The high rate of distant failure after RT, with or without surgery, reflected the lack of a consensus regarding the best therapeutic approach for treating carcinoma of the EAC and middle ear.

Keywords

References

  1. Koto M, Hasegawa A, Takagi R, Sasahara G, Ikawa H, Mizoe JE, et al. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear. Head Neck. 2016;38:512-6. https://doi.org/10.1002/hed.23905
  2. Kuhel WI, Hume CR, Selesnick SH. Cancer of the external auditory canal and temporal bone. Otolaryngol Clin North Am. 1996;29:827-52.
  3. Nakagawa T, Kumamoto Y, Natori Y, Shiratsuchi H, Toh S, Kakazu Y, et al. Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol. 2006;27:242-8. https://doi.org/10.1097/01.mao.0000190463.88873.3d
  4. Pfreundner L, Schwager K, Willner J, Baier K, Bratengeier K, Brunner FX, et al. Carcinoma of the external auditory canal and middle ear. Int J Radiat Oncol Biol Phys. 1999;44:777-88. https://doi.org/10.1016/S0360-3016(98)00531-8
  5. Boamah H, Knight G, Taylor J, Palka K, Ballard B. Squamous cell carcinoma of the external auditory canal: a case report. Case Rep Otolaryngol. 2011;2011:615210.
  6. Korzeniowski S, Pszon J. The results of radiotherapy of cancer of the middle ear. Int J Radiat Oncol Biol Phys. 1990;18:631-3. https://doi.org/10.1016/0360-3016(90)90071-Q
  7. Gabriele P, Magnano M, Albera R, Canale G, Redda MG, Krengli M, et al. Carcinoma of the external auditory meatus and middle ear: results of the treatment of 28 cases. Tumori. 1994;80:40-3. https://doi.org/10.1177/030089169408000108
  8. Waldemar E, Sorensen T, Bretlau P, Hansen HS. Cancer in the middle ear and the auditory canal. Ugeskr Laeger. 1995;157:2139-42.
  9. Spector JG. Management of temporal bone carcinomas: a therapeutic analysis of two groups of patients and long-term followup. Otolaryngol Head Neck Surg. 1991;104:58-66. https://doi.org/10.1177/019459989110400112
  10. Chen WY, Kuo SH, Chen YH, Lu SH, Tsai CL, Cheng JC, et al. Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: treatment outcomes, marginal misses, and perspective on target delineation. Int J Radiat Oncol Biol Phys. 2012;82:1485-93. https://doi.org/10.1016/j.ijrobp.2011.05.018
  11. Arriaga M, Curtin H, Takahashi H, Hirsch BE, Kamerer DB. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol. 1990;99(9 Pt 1):714-21. https://doi.org/10.1177/000348949009900909
  12. Pemberton LS, Swindell R, Sykes AJ. Primary radical radiotherapy for squamous cell carcinoma of the middle ear and external auditory cana: an historical series. Clin Oncol (R Coll Radiol). 2006;18:390-4. https://doi.org/10.1016/j.clon.2006.03.001
  13. Ogawa K, Nakamura K, Hatano K, Uno T, Fuwa N, Itami J, et al. Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients. Int J Radiat Oncol Biol Phys. 2007;68:1326-34. https://doi.org/10.1016/j.ijrobp.2007.01.052
  14. Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol. 2000;21:582-8.
  15. Takenaka Y, Cho H, Nakahara S, Yamamoto Y, Yasui T, Inohara H. Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: a meta-analysis. Head Neck. 2015;37:1073-80. https://doi.org/10.1002/hed.23698
  16. Prabhu R, Hinerman RW, Indelicato DJ, Morris CG, Werning JW, Vaysberg M, et al. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy. Am J Clin Oncol. 2009;32:401-4. https://doi.org/10.1097/COC.0b013e31818f2d48
  17. Prasad S, Janecka IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg. 1994;110:270-80. https://doi.org/10.1177/019459989411000303
  18. Kinney SE. Squamous cell carcinoma of the external auditory canal. Am J Otol. 1989;10:111-6.
  19. Chang CH, Shu MT, Lee JC, Leu YS, Chen YC, Lee KS. Treatments and outcomes of malignant tumors of external auditory canal. Am J Otolaryngol. 2009;30:44-8. https://doi.org/10.1016/j.amjoto.2008.02.007
  20. Arthur K. Radiotherapy in carcinoma of the middle ear and auditory canal. J Laryngol Otol. 1976;90:753-62. https://doi.org/10.1017/S0022215100082657
  21. Hashi N, Shirato H, Omatsu T, Kagei K, Nishioka T, Hashimoto S, et al. The role of radiotherapy in treating squamous cell carcinoma of the external auditory canal, especially in early stages of disease. Radiother Oncol. 2000;56:221-5. https://doi.org/10.1016/S0167-8140(00)00220-6
  22. Gillespie MB, Francis HW, Chee N, Eisele DW. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg. 2001;127:803-7.
  23. Leong SC, Youssef A, Lesser TH. Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy. Laryngoscope. 2013;123:2442-8.

Cited by

  1. 원발성 외이도암의 재발 양상 vol.33, pp.1, 2017, https://doi.org/10.21593/kjhno/2017.33.1.15
  2. Surgery With or Without Postoperative Radiation Therapy for Early-stage External Auditory Canal Squamous Cell Carcinoma: A Meta-analysis vol.38, pp.9, 2017, https://doi.org/10.1097/mao.0000000000001533
  3. A retrospective multicenter study of carbon‐ion radiotherapy for external auditory canal and middle ear carcinomas vol.8, pp.1, 2017, https://doi.org/10.1002/cam4.1830
  4. Management of Temporal Bone Malignancy in Ireland vol.81, pp.6, 2020, https://doi.org/10.1055/s-0039-1696723
  5. Evaluating the prognostic contributions of TNM classifications and building novel staging schemes for middle ear squamous cell carcinoma vol.10, pp.22, 2017, https://doi.org/10.1002/cam4.4306